Grants per year
Fingerprint
Dive into the research topics where Immunotherapy, Vaccines and Virotherapy, Center for (CIVV) is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Ariel Anbar
- Arizona State University, Sustainability Initiative - President's Professor
- Arizona State University, Molecular Sciences, School of (SMS) - President's Professor
- Arizona State University, Immunotherapy, Vaccines and Virotherapy, Center for (CIVV) - President's Professor
- Arizona State University, Meteorite Studies, Center for - President's Professor
- Arizona State University, Earth and Space Exploration, School of (SESE) - President's Professor
- Arizona State University, Teachers College, Mary Lou Fulton (MLFTC) - President's Professor
Person
-
Jennifer Barrila
- Arizona State University, Immunotherapy, Vaccines and Virotherapy, Center for (CIVV) - Research Assistant Professor
- Arizona State University, Fundamental and Applied Microbiomics, Center for (FAM) - Research Assistant Professor
Person
-
Heather Bean
- Arizona State University, Immunotherapy, Vaccines and Virotherapy, Center for (CIVV) - Associate Professor
- Arizona State University, Life Sciences, School of (SOLS) - Associate Professor
- Arizona State University, Fundamental and Applied Microbiomics, Center for (FAM) - Associate Professor
Person
-
Mimicking the gut environment to define mast cell responses to food allergens - Renewal - 1
Food Allergy Science Initiative (FASI)
7/1/22 → 6/30/23
Project: Research project
-
A novel vaccine platform that eliminates the side effect of antibody-dependent enhancement of infection
7/1/22 → 6/30/23
Project: Research project
-
Canonical cellular stress granules are required for arsenite-induced necroptosis mediated by Z-DNA- binding protein 1
Szczerba, M., Johnson, B., Acciai, F., Gogerty, C., McCaughan, M., Williams, J., Kibler, K. & Jacobs, B. L., Mar 14 2023, In: Science signaling. 16, 776, eabq0837.Research output: Contribution to journal › Article › peer-review
-
Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma
Jazowiecka-Rakus, J., Sochanik, A., Hadryś, A., Fidyk, W., Chmielik, E., Rahman, M. M. & McFadden, G., Apr 1 2022, In: Cancers. 14, 8, 2022.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Induction of tumor cell autosis by myxoma virus-infected CAR-T and TCR-T cells to overcome primary and acquired resistance
Zheng, N., Fang, J., Xue, G., Wang, Z., Li, X., Zhou, M., Jin, G., Rahman, M. M., McFadden, G. & Lu, Y., Sep 12 2022, In: Cancer cell. 40, 9, p. 973-985.e7Research output: Contribution to journal › Article › peer-review
4 Scopus citations
Press/Media
-
US Patent Issued to Arizona Board of Regents on behalf of Arizona State University on Oct. 4 for "Pharmaceutical compositions comprising caffeic acid chelates" (Arizona Inventors)
10/5/22
1 item of Media coverage
Press/Media: Press / Media
-
Ric Scalzo Institute Of Botanical Research And Kelai Pharmaceutical Announce Research Partnership
5/31/22
10 items of Media coverage
Press/Media: Press / Media
-
Ric Scalzo Institute of Botanical Research and Kelai Pharmaceutical Announce Research Partnership.
5/31/22
1 item of Media coverage
Press/Media: Press / Media
Equipment
-
Biodesign: CIDV Core Facility
Immunotherapy, Vaccines and Virotherapy, Center for (CIVV)Equipment/facility: Facility
-
Biodesign: Fluorescence Assisted Cell Sorting Facility
Yung Chang (Manager)
Immunotherapy, Vaccines and Virotherapy, Center for (CIVV)Equipment/facility: Facility